Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.

Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, Sandercock PA; IST-3 Collaborative Group..

Stroke. 2015 Mar;46(3):746-56. doi: 10.1161/STROKEAHA.114.006573. Epub 2015 Jan 22. Erratum in: Stroke. 2015 Mar;46(3):e73.

2.

Is the 'liberation procedure' for multiple sclerosis really liberating?

Hankey GJ, Sandercock P, Cantisani TA, Celani MG.

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):362. doi: 10.1136/jnnp-2013-305788. Epub 2013 Aug 20. No abstract available.

PMID:
23962619
3.

An old drug for a common disease.

Cantisani TA, Celani MG, Hankey GJ, Sandercock PA.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):473-4. doi: 10.1136/jnnp-2012-304183. Epub 2012 Dec 12. No abstract available.

PMID:
23236015
4.

Secondary progressive multiple sclerosis: a shared therapeutic decision.

Cantisani TA, Celani MG, Hankey GJ, Sandercock PA.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):365. doi: 10.1136/jnnp-2012-303884. Epub 2012 Dec 6. No abstract available.

PMID:
23223334
5.

Piracetam for acute ischaemic stroke.

Ricci S, Celani MG, Cantisani TA, Righetti E.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000419. doi: 10.1002/14651858.CD000419.pub3. Review.

PMID:
22972044
6.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group., Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

7.

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group..

Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252.

8.

Acrofrontofacionasal dysostosis 1 in two sisters of Indian origin.

Prontera P, Urciuoli R, Siliquini S, Macone S, Stangoni G, Donti E, Cantisani TA, Elia M, Belcastro V.

Am J Med Genet A. 2011 Dec;155A(12):3125-7. doi: 10.1002/ajmg.a.34295. Epub 2011 Nov 3. No abstract available.

PMID:
22052670
9.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Cusi C, Cantisani TA, Celani MG, Incorvaia B, Righetti E, Candelise L; Cochrane Neurological Network..

Neuroepidemiology. 2007;28(2):116-7. Epub 2007 Apr 4. No abstract available.

PMID:
17409773
10.

Does rivastigmine improve cognitive functions or disability in patients with Alzheimer's disease?

Cantisani TA, Celani MG, Righetti E.

Neuroepidemiology. 2004 Jul-Aug;23(4):209-10. No abstract available.

11.

Prostaglandin E1 for treatment of erectile dysfunction.

Urciuoli R, Cantisani TA, Carlini M, Giuglietti M, Botti FM.

Cochrane Database Syst Rev. 2004;(2):CD001784. Review.

PMID:
15106162
12.

Glycerol for acute stroke: a Cochrane systematic review.

Righetti E, Celani MG, Cantisani TA, Sterzi R, Boysen G, Ricci S.

J Neurol. 2002 Apr;249(4):445-51. Review.

PMID:
11967651
13.

Different measures for assessing stroke outcome: an analysis from the International Stroke Trial in Italy.

Celani MG, Cantisani TA, Righetti E, Spizzichino L, Ricci S; Italian International Stroke Trial (IST) Collaborators..

Stroke. 2002 Jan;33(1):218-23.

14.

Piracetam in acute stroke: a systematic review.

Ricci S, Celani MG, Cantisani TA, Righetti E.

J Neurol. 2000 Apr;247(4):263-6.

PMID:
10836617
15.

Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial.

Ricci S, Cantisani TA, Celani MG, Righetti E.

Lancet. 1997 Aug 9;350(9075):441; author reply 443-4. No abstract available.

PMID:
9259674
16.

So-called "petit mal status": epileptic syndrome or seizure type?

Tiacci C, D'Alessandro P, Cantisani TA, Bartocci A, Ibba A, Ferroni A.

Ital J Neurol Sci. 1995 Jun;16(5):279-94.

PMID:
8537216
17.

Bilateral median and ulnar neuropathy at the wrist in a parquet floorer.

dell'Omo M, Muzi G, Cantisani TA, Ercolani S, Accattoli MP, Abbritti G.

Occup Environ Med. 1995 Mar;52(3):211-3.

18.

Epilepsy with bilateral occipital calcifications: Sturge-Weber variant or a different encephalopathy?

Tiacci C, D'Alessandro P, Cantisani TA, Piccirilli M, Signorini E, Pelli MA, Cavalletti ML, Castellucci G, Palmeri S, Battisti C, et al.

Epilepsia. 1993 May-Jun;34(3):528-39.

PMID:
8504785
19.

Neuralgic amyotrophy of the shoulder girdle. The Parsonage-Turner syndrome.

Ferrini L, Della Torre P, Perticoni G, Cantisani TA.

Ital J Orthop Traumatol. 1986 Jun;12(2):223-31.

PMID:
3793461
20.

Polyneuropathy in workers with long exposure to vinyl chloride. Electrophysiological study.

Perticoni GF, Abbritti G, Cantisani TA, Bondi L, Mauro L.

Electromyogr Clin Neurophysiol. 1986 Jan-Feb;26(1):41-7. No abstract available.

PMID:
3017686

Supplemental Content

Loading ...
Support Center